Company profile for Aspect Biosystems

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue t...
Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body with the aim of treating currently incurable diseases such as type 1 diabetes as well as genetic and acquired liver diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
1781 West 75th Ave Vancouver, BC V6P6P2
Telephone
Telephone
+1 604 263 0502
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250714081536/en/Aspect-Biosystems-Presents-New-Preclinical-Data-on-Adrenal-Bioprinted-Tissue-Therapeutics-at-ENDO-2025

BUSINESSWIRE
14 Jul 2025

https://www.businesswire.com/news/home/20250108827523/en

BUSINESSWIRE
08 Jan 2025

https://www.businesswire.com/news/home/20241008164117/en

BUSINESSWIRE
09 Oct 2024
Aspect wins $72.75m from Canadian government for bioprinted pipeline
Aspect wins $72.75m from Canadian government for bioprinted pipeline

11 Jul 2024

// Jenna Philpott PHARMACEUTICAL-TECHNOLOGY

https://www.pharmaceutical-technology.com/news/aspect-wins-72-75m-from-canadian-government-for-bioprinted-pipeline/

Jenna Philpott PHARMACEUTICAL-TECHNOLOGY
11 Jul 2024

https://www.businesswire.com/news/home/20240710896489/en

BUSINESSWIRE
10 Jul 2024

https://www.businesswire.com/news/home/20240104941925/en

BUSINESSWIRE
04 Jan 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty